About Halyard Health (NYSE:HYH)
Halyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. The Company address healthcare needs, such as reducing the use of opioids, while helping patients move from surgery to recovery. The Medical Devices segment's products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes. The S&IP segment includes product offerings, such as sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.
Industry, Sector and Symbol
Industry MED PRODS
Trailing P/E Ratio20.29
Forward P/E Ratio48.96
Sales & Book Value
Annual Sales$611.60 million
Price / Sales3.61
Cash Flow$1.24 per share
Price / Cash37.88
Book Value$25.95 per share
Price / Book1.81
Net Income$79.30 million
Return on Equity6.98%
Return on Assets3.82%
Halyard Health (NYSE:HYH) Frequently Asked Questions
What is Halyard Health's stock symbol?
Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."
How were Halyard Health's earnings last quarter?
Halyard Health Inc (NYSE:HYH) released its earnings results on Tuesday, February, 27th. The medical instruments supplier reported $0.73 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.50 by $0.23. The medical instruments supplier had revenue of $428.10 million for the quarter, compared to analysts' expectations of $413.94 million. Halyard Health had a net margin of 5.82% and a return on equity of 6.98%. The company's quarterly revenue was up 4.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.50 earnings per share. View Halyard Health's Earnings History.
Where is Halyard Health's stock going? Where will Halyard Health's stock price be in 2018?
4 equities research analysts have issued 1 year target prices for Halyard Health's stock. Their forecasts range from $42.00 to $52.00. On average, they anticipate Halyard Health's share price to reach $47.00 in the next year. View Analyst Ratings for Halyard Health.
Who are some of Halyard Health's key competitors?
Some companies that are related to Halyard Health include Penumbra (PEN), LivaNova (LIVN), Haemonetics (HAE), Aurora Cannabis (ACBFF), ELEKTA (EKTAY), Abcam (ABCZY), BTG (BTGGF), Neogen (NEOG), GW Pharmaceuticals PLC- (GWPH), Inogen (INGN), NuVasive (NUVA), Nevro (NVRO), National Vision (EYE), Merit Medical Systems (MMSI), Wright Medical Group (WMGI), Patterson Companies (PDCO), Opko Health (OPK) and Integer (ITGR).
Who are Halyard Health's key executives?
Halyard Health's management team includes the folowing people:
- Ronald W. Dollens, Chairman of the Board (Age 70)
- Joseph F. Woody, Chief Executive Officer, Director (Age 51)
- Steven E. Voskuil, Chief Financial Officer, Senior Vice President (Age 48)
- Rhonda D. Gibby, Chief Human Resource Officer, Senior Vice President (Age 49)
- John W. Wesley, Senior Vice President, General Counsel (Age 59)
- Christopher G. Isenberg, Senior Vice President - Global Supply Chain and Procurement (Age 50)
- Warren J. Machan, Senior Vice President - Business Strategy (Age 51)
- Gary D. Blackford, Independent Director (Age 60)
- John P. Byrnes, Independent Director (Age 58)
- William A. Hawkins III, Independent Director (Age 62)
Has Halyard Health been receiving favorable news coverage?
News coverage about HYH stock has trended positive recently, Accern reports. The research group scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Halyard Health earned a daily sentiment score of 0.27 on Accern's scale. They also assigned media stories about the medical instruments supplier an impact score of 44.55 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
Who are Halyard Health's major shareholders?
Halyard Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.55%), Goldman Sachs Group Inc. (3.65%), Paradice Investment Management LLC (3.24%), Bank of New York Mellon Corp (1.96%), Macquarie Group Ltd. (1.83%) and Copper Rock Capital Partners LLC (1.45%). View Institutional Ownership Trends for Halyard Health.
Which institutional investors are selling Halyard Health stock?
HYH stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Schwab Charles Investment Management Inc., Gotham Asset Management LLC, Northpointe Capital LLC, Paradice Investment Management LLC, Metropolitan Life Insurance Co. NY, TIAA CREF Investment Management LLC and Guggenheim Capital LLC. View Insider Buying and Selling for Halyard Health.
Which institutional investors are buying Halyard Health stock?
HYH stock was purchased by a variety of institutional investors in the last quarter, including Channing Capital Management LLC, Macquarie Group Ltd., Deutsche Bank AG, Millennium Management LLC, Allianz Asset Management GmbH, Goldman Sachs Group Inc., MetLife Investment Advisors LLC and State of Wisconsin Investment Board. View Insider Buying and Selling for Halyard Health.
How do I buy shares of Halyard Health?
Shares of HYH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Halyard Health's stock price today?
One share of HYH stock can currently be purchased for approximately $47.00.
How big of a company is Halyard Health?
Halyard Health has a market capitalization of $2.21 billion and generates $611.60 million in revenue each year. The medical instruments supplier earns $79.30 million in net income (profit) each year or $1.67 on an earnings per share basis. Halyard Health employs 13,000 workers across the globe.
How can I contact Halyard Health?
Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected]
MarketBeat Community Rating for Halyard Health (HYH)MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Halyard Health (NYSE:HYH) Earnings History and Estimates Chart
Halyard Health (NYSE HYH) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/27/2018||Q4 2017||$0.50||$0.73||$413.94 million||$428.10 million||View||N/A|
|11/1/2017||Q3 2017||$0.47||$0.60||$394.54 million||$401.40 million||View||N/A|
|8/2/2017||Q2 2017||$0.37||$0.51||$399.16 million||$399.20 million||View||Listen|
|5/2/2017||Q1 2017||$0.43||$0.48||$391.56 million||$395.60 million||View||Listen|
|2/27/2017||Q416||$0.44||$0.50||$401.72 million||$410.00 million||View||Listen|
|11/2/2016||Q316||$0.39||$0.48||$387.64 million||$398.00 million||View||N/A|
|8/3/2016||Q216||$0.36||$0.45||$383.08 million||$400.00 million||View||N/A|
|5/4/2016||Q116||$0.34||$0.53||$369.80 million||$385.00 million||View||N/A|
|2/29/2016||Q415||$0.50||$0.57||$401.96 million||$401.40 million||View||Listen|
|11/3/2015||Q315||$0.47||$0.52||$388.00 million||$390.00 million||View||N/A|
|8/4/2015||Q215||$0.53||$0.52||$401.70 million||$389.30 million||View||N/A|
|5/4/2015||Q1 2015||$0.64||$0.51||$390.00 million||$394.00 million||View||N/A|
|3/4/2015||Q4||$0.75||$1.59||$425.10 million||$439.40 million||View||N/A|
Halyard Health (NYSE:HYH) Earnings Estimates
2018 EPS Consensus Estimate: $0.82
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Halyard Health (NYSE:HYH)
No dividend announcements for this company have been tracked by MarketBeat.com
Halyard Health (NYSE HYH) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.44%
Institutional Ownership Percentage: 91.32%
Halyard Health (NYSE HYH) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|9/4/2015||Robert E Abernathy||CEO||Buy||10,000||$31.06||$310,600.00||80,043|| |
|9/1/2015||Steven E Voskuil||CFO||Buy||1,000||$30.00||$30,000.00||28,729|| |
Halyard Health (NYSE HYH) News Headlines
| Brokerages Expect Halyard Health Inc (HYH) Will Announce Quarterly Sales of $153.20 Million|
www.americanbankingnews.com - March 9 at 2:23 PM
|Halyard Health Upgrades ON-Q* TRAC Patient Engagement Platform for Physicians and Hospitals|
finance.yahoo.com - March 9 at 8:39 AM
|Halyard Health, Inc. to Present at the Barclays Global Healthcare Conference|
finance.yahoo.com - March 7 at 8:38 AM
|Cove Street Capital LLC Has $16.60 Million Holdings in Halyard Health Inc (HYH)|
www.americanbankingnews.com - March 5 at 4:07 PM
|Swiss National Bank Buys 1,800 Shares of Halyard Health Inc (HYH)|
www.americanbankingnews.com - March 5 at 4:03 PM
|KeyCorp Weighs in on Halyard Health Inc's Q1 2018 Earnings (HYH)|
www.americanbankingnews.com - March 5 at 2:08 AM
|State of Wisconsin Investment Board Acquires Shares of 50,000 Halyard Health Inc (HYH)|
www.americanbankingnews.com - March 4 at 9:32 AM
|Halyard Health (HYH) Raised to Strong-Buy at Zacks Investment Research|
www.americanbankingnews.com - March 2 at 11:56 PM
|Channing Capital Management LLC Acquires New Holdings in Halyard Health Inc (HYH)|
www.americanbankingnews.com - March 2 at 5:32 AM
|Analysts’ Ratings for Integer Holdings Corporation and Peers|
finance.yahoo.com - March 1 at 8:27 AM
|Exploring the Business Segments of Integer Holdings Corporation|
finance.yahoo.com - March 1 at 8:27 AM
|The Geographic Segments of Integer Holdings Corporation|
finance.yahoo.com - March 1 at 8:27 AM
|Halyard Health (HYH) Upgraded at ValuEngine|
www.americanbankingnews.com - February 28 at 10:16 PM
|Halyard Health Inc (HYH) Given Consensus Rating of "Buy" by Brokerages|
www.americanbankingnews.com - February 28 at 9:28 PM
|Halyard Health, Inc. to Present at the Raymond James 39th Annual Institutional ...|
www.prnewswire.com - February 28 at 5:51 PM
|Systematic Financial Management LP Decreases Stake in Halyard Health Inc (HYH)|
www.americanbankingnews.com - February 28 at 5:46 PM
|Halyard Health, Inc. to Present at the Raymond James 39th Annual Institutional Investors Conference|
finance.yahoo.com - February 28 at 8:31 AM
|Halyard tops 4Q profit forecasts|
finance.yahoo.com - February 27 at 5:44 PM
|Halyard Health (HYH) Releases Quarterly Earnings Results, Beats Estimates By $0.23 EPS|
www.americanbankingnews.com - February 27 at 11:36 AM
|Halyard Health, Inc. Announces Fourth Quarter and Full-Year 2017 Results|
www.bizjournals.com - February 27 at 8:35 AM
|Is Halyard Health Inc (NYSE:HYH) A Sell At Its Current PE Ratio?|
finance.yahoo.com - February 27 at 8:35 AM
|Spark Investment Management LLC Has $7.89 Million Position in Halyard Health Inc (HYH)|
www.americanbankingnews.com - February 26 at 3:02 PM
|Aperio Group LLC Has $1.57 Million Holdings in Halyard Health Inc (HYH)|
www.americanbankingnews.com - February 24 at 5:00 AM
|Halyard Health (HYH) Scheduled to Post Quarterly Earnings on Monday|
www.americanbankingnews.com - February 19 at 4:30 AM
| Analysts Anticipate Halyard Health Inc (HYH) to Post $0.49 Earnings Per Share|
www.americanbankingnews.com - February 18 at 1:34 PM
|Halyard Health, Inc. To Webcast Conference Call Discussing Fourth Quarter and Full-Year 2017 Financial Results|
finance.yahoo.com - February 13 at 9:52 AM
|Halyard Health Inc (HYH) Given Average Rating of "Buy" by Brokerages|
www.americanbankingnews.com - February 3 at 9:36 PM
|Halyard Health Inc (HYH) Expected to Announce Quarterly Sales of $417.93 Million|
www.americanbankingnews.com - February 3 at 4:38 AM
|Halyard Health (HYH) Downgraded by Zacks Investment Research to Hold|
www.americanbankingnews.com - February 2 at 12:36 AM
| Brokerages Expect Halyard Health Inc (HYH) Will Announce Earnings of $0.49 Per Share|
www.americanbankingnews.com - January 15 at 3:08 PM
|Head-To-Head Analysis: Meridian Bioscience (VIVO) & Halyard Health (HYH)|
www.americanbankingnews.com - January 13 at 11:26 AM
|Wired News – Owens & Minor Plans to Reorganize Business into Two Segments Post Acquisition of Halyard Health's S&IP Business|
finance.yahoo.com - January 8 at 8:26 AM
|Halyard Health (HYH) Upgraded to Buy at Zacks Investment Research|
www.americanbankingnews.com - January 7 at 6:40 PM
|Halyard Health, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference|
finance.yahoo.com - January 3 at 10:54 AM
|Halyard Health (HYH) Upgraded to "Buy" at ValuEngine|
www.americanbankingnews.com - January 1 at 10:28 PM
|Halyard Health, Inc. breached its 50 day moving average in a Bearish Manner : HYH-US : January 1, 2018|
finance.yahoo.com - January 1 at 11:07 AM
|Zacks: Analysts Anticipate Halyard Health Inc (HYH) Will Announce Quarterly Sales of $417.93 Million|
www.americanbankingnews.com - December 31 at 3:58 AM
|Halyard Health, Inc. (HYH)|
finance.yahoo.com - December 30 at 3:36 PM
|$0.50 Earnings Per Share Expected for Halyard Health Inc (HYH) This Quarter|
www.americanbankingnews.com - December 29 at 7:24 PM
|ETFs with exposure to Halyard Health, Inc. : December 21, 2017|
finance.yahoo.com - December 21 at 3:39 PM
|Halyard Health Earns Relative Strength Rating Upgrade; Hits Key Threshold|
finance.yahoo.com - December 20 at 11:30 AM
|Halyard Health Inc (HYH) Receives Average Recommendation of "Buy" from Analysts|
www.americanbankingnews.com - December 15 at 7:43 PM
|Halyard Health, Inc. (HYH) Expected to Announce Earnings of $0.50 Per Share|
www.americanbankingnews.com - December 12 at 3:28 PM
|Halyard Health (HYH) Rating Increased to Buy at Zacks Investment Research|
www.americanbankingnews.com - December 10 at 12:08 AM
|Comparing Halyard Health (HYH) & Its Competitors|
www.americanbankingnews.com - December 8 at 9:08 PM
|Halyard Health (HYH) Raised to "B" at TheStreet|
www.americanbankingnews.com - December 6 at 10:38 PM
|Financial Review: Halyard Health (HYH) versus Its Competitors|
www.americanbankingnews.com - December 3 at 1:24 AM
|Comparing Halyard Health (HYH) & The Competition|
www.americanbankingnews.com - December 2 at 9:38 AM
|ETFs with exposure to Halyard Health, Inc. : December 1, 2017|
finance.yahoo.com - December 1 at 4:46 PM
|$418.06 Million in Sales Expected for Halyard Health, Inc. (HYH) This Quarter|
www.americanbankingnews.com - November 26 at 2:52 AM
Halyard Health (NYSE:HYH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Halyard Health (NYSE:HYH) Income Statement, Balance Sheet and Cash Flow Statement
Halyard Health (NYSE HYH) Stock Chart for Thursday, March, 22, 2018